Biosynex Nordic ApS: Financial statements 2022
CVR: 38417541
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Biosynex Nordic ApS (CVR 38417541) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 52,128,274 and a net result of DKK 41,802,660 compared with DKK 49,728,503 the year before. That is a decrease of 20.3% compared with the year before. Equity in the 2022 report amounted to DKK 117,616. The solvency ratio was 0.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 52,128,274
- Profit/Loss
- DKK 41,802,660
- Equity
- DKK 117,616
- Total Assets
- DKK 15,082,051
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 52.1M | 41.8M | 118K | 2 |
| 2021 | - | 65.4M | 49.7M | 40.1M | 1 |
| 2020 | - | 5.1M | 4M | 4.2M | 0 |
| 2019 | - | 231K | 178K | 199K | 0 |
| 2018 | - | -35K | -29K | 21K | 0 |
Official annual report
Keep an eye on Biosynex Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 20, 2022, Jacques Cavadenti has joined the board of directors of Biosynex Nordic ApS.
As of December 20, 2022, Thomas Lamy has joined the board of directors of Biosynex Nordic ApS.
As of December 20, 2022, Thierry Paper has joined the board of directors of Biosynex Nordic ApS.
As of December 20, 2022, Larry Abensur has joined the board of directors of Biosynex Nordic ApS.
As of December 20, 2022, Michael Lexner has left the board of directors of Biosynex Nordic ApS.
Biosynex Nordic ApS has published its annual report for 2021. Gross profit came to DKK 65,446,511, and the net result was DKK 49,728,503.
About Biosynex Nordic ApS
Biosynex Nordic ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 7 July 2025. The company was registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named Biosynex Nordic A/S and Medkoncept A/S. The company has 2 employees (2025). In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178.